nodes	percent_of_prediction	percent_of_DWPC	metapath
Proparacaine—Lacrimation—Estramustine—prostate cancer	0.0473	0.105	CcSEcCtD
Proparacaine—Lacrimation increased—Estramustine—prostate cancer	0.0302	0.0669	CcSEcCtD
Proparacaine—Allergic contact dermatitis—Estradiol—prostate cancer	0.0281	0.0623	CcSEcCtD
Proparacaine—Lacrimation increased—Cabazitaxel—prostate cancer	0.0225	0.0499	CcSEcCtD
Proparacaine—Necrosis—Conjugated Estrogens—prostate cancer	0.0156	0.0347	CcSEcCtD
Proparacaine—Necrosis—Mitoxantrone—prostate cancer	0.0117	0.0258	CcSEcCtD
Proparacaine—Lacrimation—Docetaxel—prostate cancer	0.0108	0.0238	CcSEcCtD
Proparacaine—Metoclopramide—CYP17A1—prostate cancer	0.0104	0.182	CrCbGaD
Proparacaine—Dermatitis contact—Estradiol—prostate cancer	0.0097	0.0215	CcSEcCtD
Proparacaine—Necrosis—Etoposide—prostate cancer	0.00969	0.0215	CcSEcCtD
Proparacaine—Procainamide—DNMT1—prostate cancer	0.00964	0.168	CrCbGaD
Proparacaine—Keratitis—Capecitabine—prostate cancer	0.00944	0.0209	CcSEcCtD
Proparacaine—Liver disorder—Docetaxel—prostate cancer	0.00928	0.0206	CcSEcCtD
Proparacaine—Haemoglobin—Bicalutamide—prostate cancer	0.00898	0.0199	CcSEcCtD
Proparacaine—Haemorrhage—Bicalutamide—prostate cancer	0.00894	0.0198	CcSEcCtD
Proparacaine—Pain—Estrone—prostate cancer	0.0081	0.018	CcSEcCtD
Proparacaine—Necrosis—Docetaxel—prostate cancer	0.00806	0.0179	CcSEcCtD
Proparacaine—Haemoglobin—Ethinyl Estradiol—prostate cancer	0.00759	0.0168	CcSEcCtD
Proparacaine—Haemorrhage—Ethinyl Estradiol—prostate cancer	0.00756	0.0168	CcSEcCtD
Proparacaine—Pain—Nilutamide—prostate cancer	0.00752	0.0167	CcSEcCtD
Proparacaine—Lacrimation—Epirubicin—prostate cancer	0.00725	0.0161	CcSEcCtD
Proparacaine—Pain—Estradiol valerate/Dienogest—prostate cancer	0.00707	0.0157	CcSEcCtD
Proparacaine—Necrosis—Prednisone—prostate cancer	0.00695	0.0154	CcSEcCtD
Proparacaine—Lacrimation increased—Docetaxel—prostate cancer	0.00686	0.0152	CcSEcCtD
Proparacaine—Pain—Degarelix—prostate cancer	0.00672	0.0149	CcSEcCtD
Proparacaine—Lacrimation—Doxorubicin—prostate cancer	0.00671	0.0149	CcSEcCtD
Proparacaine—Lacrimation increased—Capecitabine—prostate cancer	0.00664	0.0147	CcSEcCtD
Proparacaine—Keratitis—Epirubicin—prostate cancer	0.00658	0.0146	CcSEcCtD
Proparacaine—Pain—Cabazitaxel—prostate cancer	0.00633	0.014	CcSEcCtD
Proparacaine—Procainamide—SLC22A3—prostate cancer	0.0063	0.11	CrCbGaD
Proparacaine—Haemoglobin—Goserelin—prostate cancer	0.00625	0.0139	CcSEcCtD
Proparacaine—Haemorrhage—Goserelin—prostate cancer	0.00622	0.0138	CcSEcCtD
Proparacaine—Keratitis—Doxorubicin—prostate cancer	0.00608	0.0135	CcSEcCtD
Proparacaine—Procainamide—ACHE—prostate cancer	0.0057	0.0996	CrCbGaD
Proparacaine—Amiodarone—CYP3A5—prostate cancer	0.0055	0.0961	CrCbGaD
Proparacaine—Necrosis—Epirubicin—prostate cancer	0.00543	0.012	CcSEcCtD
Proparacaine—Pain—Bicalutamide—prostate cancer	0.00543	0.012	CcSEcCtD
Proparacaine—Amiodarone—CYP2A6—prostate cancer	0.00533	0.0931	CrCbGaD
Proparacaine—Stinging—Epirubicin—prostate cancer	0.00526	0.0117	CcSEcCtD
Proparacaine—Necrosis—Doxorubicin—prostate cancer	0.00503	0.0111	CcSEcCtD
Proparacaine—Haemoglobin—Estradiol—prostate cancer	0.00495	0.011	CcSEcCtD
Proparacaine—Haemorrhage—Estradiol—prostate cancer	0.00493	0.0109	CcSEcCtD
Proparacaine—Stinging—Doxorubicin—prostate cancer	0.00487	0.0108	CcSEcCtD
Proparacaine—Lacrimation increased—Epirubicin—prostate cancer	0.00463	0.0103	CcSEcCtD
Proparacaine—Haemoglobin—Mitoxantrone—prostate cancer	0.00462	0.0102	CcSEcCtD
Proparacaine—Haemorrhage—Mitoxantrone—prostate cancer	0.00459	0.0102	CcSEcCtD
Proparacaine—Procainamide—SLC22A1—prostate cancer	0.00452	0.0789	CrCbGaD
Proparacaine—Lacrimation increased—Doxorubicin—prostate cancer	0.00428	0.00949	CcSEcCtD
Proparacaine—Dermatitis contact—Epirubicin—prostate cancer	0.00421	0.00935	CcSEcCtD
Proparacaine—Dermatitis contact—Doxorubicin—prostate cancer	0.0039	0.00865	CcSEcCtD
Proparacaine—Pain—Goserelin—prostate cancer	0.00378	0.00838	CcSEcCtD
Proparacaine—Amiodarone—CYP2C19—prostate cancer	0.00375	0.0654	CrCbGaD
Proparacaine—Pain—Conjugated Estrogens—prostate cancer	0.00374	0.0083	CcSEcCtD
Proparacaine—Amiodarone—CYP1A1—prostate cancer	0.00373	0.0652	CrCbGaD
Proparacaine—Haemoglobin—Docetaxel—prostate cancer	0.00319	0.00708	CcSEcCtD
Proparacaine—Haemorrhage—Docetaxel—prostate cancer	0.00318	0.00704	CcSEcCtD
Proparacaine—Haemoglobin—Capecitabine—prostate cancer	0.00309	0.00685	CcSEcCtD
Proparacaine—Haemorrhage—Capecitabine—prostate cancer	0.00307	0.00682	CcSEcCtD
Proparacaine—Pain—Estradiol—prostate cancer	0.00299	0.00664	CcSEcCtD
Proparacaine—Pain—Mitoxantrone—prostate cancer	0.00279	0.00619	CcSEcCtD
Proparacaine—Haemoglobin—Prednisone—prostate cancer	0.00275	0.0061	CcSEcCtD
Proparacaine—Haemorrhage—Prednisone—prostate cancer	0.00274	0.00607	CcSEcCtD
Proparacaine—Amiodarone—CYP3A4—prostate cancer	0.00238	0.0416	CrCbGaD
Proparacaine—SCN3A—Developmental Biology—FARP2—prostate cancer	0.00233	0.00474	CbGpPWpGaD
Proparacaine—Pain—Etoposide—prostate cancer	0.00232	0.00515	CcSEcCtD
Proparacaine—SCN2A—Axon guidance—NRP1—prostate cancer	0.00232	0.00471	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—EPHB2—prostate cancer	0.00231	0.00469	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—FARP2—prostate cancer	0.00224	0.00456	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—NRP1—prostate cancer	0.00223	0.00454	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—NRP1—prostate cancer	0.00223	0.00454	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—EPHB2—prostate cancer	0.00223	0.00453	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—EPHB2—prostate cancer	0.00223	0.00453	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—PAK6—prostate cancer	0.00221	0.0045	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—HSP90AB1—prostate cancer	0.00219	0.00446	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—FARP2—prostate cancer	0.00216	0.00439	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—FARP2—prostate cancer	0.00216	0.00439	CbGpPWpGaD
Proparacaine—Haemoglobin—Epirubicin—prostate cancer	0.00215	0.00477	CcSEcCtD
Proparacaine—Haemorrhage—Epirubicin—prostate cancer	0.00214	0.00475	CcSEcCtD
Proparacaine—SCN2A—Developmental Biology—PAK6—prostate cancer	0.00212	0.00432	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—LAMC1—prostate cancer	0.00211	0.00429	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—HSP90AB1—prostate cancer	0.00211	0.00428	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—PAK6—prostate cancer	0.00205	0.00417	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—PAK6—prostate cancer	0.00205	0.00417	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—HSP90AB1—prostate cancer	0.00203	0.00413	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—HSP90AB1—prostate cancer	0.00203	0.00413	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—LAMC1—prostate cancer	0.00203	0.00412	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—RRAS—prostate cancer	0.00202	0.00411	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—PRNP—prostate cancer	0.002	0.00406	CbGpPWpGaD
Proparacaine—Haemoglobin—Doxorubicin—prostate cancer	0.00199	0.00442	CcSEcCtD
Proparacaine—Haemorrhage—Doxorubicin—prostate cancer	0.00198	0.00439	CcSEcCtD
Proparacaine—SCN1A—Developmental Biology—LAMC1—prostate cancer	0.00195	0.00397	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—LAMC1—prostate cancer	0.00195	0.00397	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—RRAS—prostate cancer	0.00194	0.00395	CbGpPWpGaD
Proparacaine—Pain—Docetaxel—prostate cancer	0.00193	0.00428	CcSEcCtD
Proparacaine—SCN3A—L1CAM interactions—MAP2K1—prostate cancer	0.00192	0.00391	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—PRNP—prostate cancer	0.00192	0.0039	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—EZR—prostate cancer	0.00188	0.00382	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—RRAS—prostate cancer	0.00187	0.00381	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—RRAS—prostate cancer	0.00187	0.00381	CbGpPWpGaD
Proparacaine—Pain—Capecitabine—prostate cancer	0.00187	0.00414	CcSEcCtD
Proparacaine—SCN1A—Axon guidance—PRNP—prostate cancer	0.00185	0.00376	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—PRNP—prostate cancer	0.00185	0.00376	CbGpPWpGaD
Proparacaine—SCN2A—L1CAM interactions—MAP2K1—prostate cancer	0.00185	0.00376	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—EZR—prostate cancer	0.00181	0.00367	CbGpPWpGaD
Proparacaine—SCN10A—L1CAM interactions—MAP2K1—prostate cancer	0.00178	0.00363	CbGpPWpGaD
Proparacaine—SCN1A—L1CAM interactions—MAP2K1—prostate cancer	0.00178	0.00363	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—EZR—prostate cancer	0.00174	0.00354	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—EZR—prostate cancer	0.00174	0.00354	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—NRP1—prostate cancer	0.00172	0.0035	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—HNF1B—prostate cancer	0.00172	0.0035	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—NRP1—prostate cancer	0.00165	0.00336	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—HNF1B—prostate cancer	0.00165	0.00336	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—HNF1B—prostate cancer	0.00159	0.00324	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—NRP1—prostate cancer	0.00159	0.00324	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—HNF1B—prostate cancer	0.00159	0.00324	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—NRP1—prostate cancer	0.00159	0.00324	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—HSP90AB1—prostate cancer	0.00156	0.00318	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—HSP90AB1—prostate cancer	0.0015	0.00306	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—HSP90AB1—prostate cancer	0.00145	0.00295	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—HSP90AB1—prostate cancer	0.00145	0.00295	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—PRNP—prostate cancer	0.00143	0.0029	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—MED12—prostate cancer	0.0014	0.00285	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—PRNP—prostate cancer	0.00137	0.00278	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—MED12—prostate cancer	0.00135	0.00274	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—NCOA3—prostate cancer	0.00134	0.00272	CbGpPWpGaD
Proparacaine—SCN3A—L1CAM interactions—SRC—prostate cancer	0.00134	0.00272	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—PRKCQ—prostate cancer	0.00133	0.00271	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—PRNP—prostate cancer	0.00132	0.00268	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—PRNP—prostate cancer	0.00132	0.00268	CbGpPWpGaD
Proparacaine—Pain—Epirubicin—prostate cancer	0.0013	0.00289	CcSEcCtD
Proparacaine—SCN1A—Developmental Biology—MED12—prostate cancer	0.0013	0.00264	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—MED12—prostate cancer	0.0013	0.00264	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—NCOA3—prostate cancer	0.00129	0.00262	CbGpPWpGaD
Proparacaine—SCN2A—L1CAM interactions—SRC—prostate cancer	0.00128	0.00261	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—PRKCQ—prostate cancer	0.00128	0.0026	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—NCOA3—prostate cancer	0.00124	0.00252	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—NCOA3—prostate cancer	0.00124	0.00252	CbGpPWpGaD
Proparacaine—SCN10A—L1CAM interactions—SRC—prostate cancer	0.00124	0.00252	CbGpPWpGaD
Proparacaine—SCN1A—L1CAM interactions—SRC—prostate cancer	0.00124	0.00252	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—PRKCQ—prostate cancer	0.00123	0.00251	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—PRKCQ—prostate cancer	0.00123	0.00251	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—VAV3—prostate cancer	0.00122	0.00248	CbGpPWpGaD
Proparacaine—Pain—Doxorubicin—prostate cancer	0.0012	0.00267	CcSEcCtD
Proparacaine—SCN2A—Axon guidance—VAV3—prostate cancer	0.00117	0.00239	CbGpPWpGaD
Proparacaine—SCN3A—L1CAM interactions—EGFR—prostate cancer	0.00117	0.00238	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—VAV3—prostate cancer	0.00113	0.0023	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—VAV3—prostate cancer	0.00113	0.0023	CbGpPWpGaD
Proparacaine—SCN2A—L1CAM interactions—EGFR—prostate cancer	0.00112	0.00229	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—NCOA2—prostate cancer	0.00112	0.00227	CbGpPWpGaD
Proparacaine—SCN10A—L1CAM interactions—EGFR—prostate cancer	0.00108	0.0022	CbGpPWpGaD
Proparacaine—SCN1A—L1CAM interactions—EGFR—prostate cancer	0.00108	0.0022	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—NCOA2—prostate cancer	0.00107	0.00218	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—ITGB3—prostate cancer	0.00105	0.00213	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—NCOA2—prostate cancer	0.00104	0.00211	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—NCOA2—prostate cancer	0.00104	0.00211	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—ITGB3—prostate cancer	0.00101	0.00205	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—ITGB3—prostate cancer	0.000972	0.00198	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—ITGB3—prostate cancer	0.000972	0.00198	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—PRKCQ—prostate cancer	0.000951	0.00193	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—NCOA1—prostate cancer	0.000942	0.00192	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—PRKCQ—prostate cancer	0.000914	0.00186	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—NCOA1—prostate cancer	0.000905	0.00184	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—FGF10—prostate cancer	0.000904	0.00184	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—RXRA—prostate cancer	0.000896	0.00182	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—KDR—prostate cancer	0.000892	0.00181	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—PRKCQ—prostate cancer	0.000881	0.00179	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—PRKCQ—prostate cancer	0.000881	0.00179	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—NCOA1—prostate cancer	0.000873	0.00178	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—NCOA1—prostate cancer	0.000873	0.00178	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—VAV3—prostate cancer	0.000872	0.00177	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—FGF10—prostate cancer	0.000868	0.00177	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—RXRA—prostate cancer	0.000861	0.00175	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—KDR—prostate cancer	0.000857	0.00174	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—VAV3—prostate cancer	0.000838	0.0017	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—FGF10—prostate cancer	0.000837	0.0017	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—FGF10—prostate cancer	0.000837	0.0017	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—RXRA—prostate cancer	0.00083	0.00169	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—RXRA—prostate cancer	0.00083	0.00169	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—KDR—prostate cancer	0.000826	0.00168	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—KDR—prostate cancer	0.000826	0.00168	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—VAV3—prostate cancer	0.000808	0.00164	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—VAV3—prostate cancer	0.000808	0.00164	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—GSK3B—prostate cancer	0.000789	0.0016	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—LPL—prostate cancer	0.000775	0.00158	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—GSK3B—prostate cancer	0.000758	0.00154	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—ITGB3—prostate cancer	0.000749	0.00152	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—LPL—prostate cancer	0.000745	0.00151	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—GSK3B—prostate cancer	0.000731	0.00149	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—GSK3B—prostate cancer	0.000731	0.00149	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—MMP2—prostate cancer	0.000728	0.00148	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—MAP2K1—prostate cancer	0.000727	0.00148	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—ITGB3—prostate cancer	0.000719	0.00146	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—LPL—prostate cancer	0.000718	0.00146	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—LPL—prostate cancer	0.000718	0.00146	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—MMP2—prostate cancer	0.0007	0.00142	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—MAP2K1—prostate cancer	0.000699	0.00142	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—ITGB3—prostate cancer	0.000694	0.00141	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—ITGB3—prostate cancer	0.000694	0.00141	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—PPARA—prostate cancer	0.000685	0.00139	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—MMP2—prostate cancer	0.000675	0.00137	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—MMP2—prostate cancer	0.000675	0.00137	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—MAP2K1—prostate cancer	0.000674	0.00137	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—MAP2K1—prostate cancer	0.000674	0.00137	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—JAK2—prostate cancer	0.000663	0.00135	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—PPARA—prostate cancer	0.000658	0.00134	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—LEP—prostate cancer	0.00065	0.00132	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—ERBB2—prostate cancer	0.000638	0.0013	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—JAK2—prostate cancer	0.000637	0.0013	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—KDR—prostate cancer	0.000637	0.00129	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—PPARA—prostate cancer	0.000634	0.00129	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—PPARA—prostate cancer	0.000634	0.00129	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—LEP—prostate cancer	0.000624	0.00127	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—JAK2—prostate cancer	0.000614	0.00125	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—JAK2—prostate cancer	0.000614	0.00125	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—ERBB2—prostate cancer	0.000613	0.00125	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—KDR—prostate cancer	0.000612	0.00124	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—LEP—prostate cancer	0.000602	0.00122	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—LEP—prostate cancer	0.000602	0.00122	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—ERBB2—prostate cancer	0.000591	0.0012	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—ERBB2—prostate cancer	0.000591	0.0012	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—KDR—prostate cancer	0.00059	0.0012	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—KDR—prostate cancer	0.00059	0.0012	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—GSK3B—prostate cancer	0.000563	0.00114	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—INS—prostate cancer	0.000555	0.00113	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—MMP9—prostate cancer	0.000547	0.00111	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—CREBBP—prostate cancer	0.000544	0.00111	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—GSK3B—prostate cancer	0.000541	0.0011	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—INS—prostate cancer	0.000533	0.00108	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—MMP9—prostate cancer	0.000526	0.00107	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—CREBBP—prostate cancer	0.000522	0.00106	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—GSK3B—prostate cancer	0.000521	0.00106	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—GSK3B—prostate cancer	0.000521	0.00106	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—MMP2—prostate cancer	0.00052	0.00106	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—MAP2K1—prostate cancer	0.000519	0.00106	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—INS—prostate cancer	0.000514	0.00105	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—INS—prostate cancer	0.000514	0.00105	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—MMP9—prostate cancer	0.000507	0.00103	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—MMP9—prostate cancer	0.000507	0.00103	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—SRC—prostate cancer	0.000505	0.00103	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—CREBBP—prostate cancer	0.000504	0.00102	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—CREBBP—prostate cancer	0.000504	0.00102	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—MMP2—prostate cancer	0.000499	0.00102	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—MAP2K1—prostate cancer	0.000499	0.00101	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—FGF2—prostate cancer	0.000494	0.001	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—VEGFA—prostate cancer	0.000491	0.000999	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—SRC—prostate cancer	0.000485	0.000986	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—MMP2—prostate cancer	0.000481	0.000979	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—MMP2—prostate cancer	0.000481	0.000979	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—MAP2K1—prostate cancer	0.000481	0.000978	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—MAP2K1—prostate cancer	0.000481	0.000978	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—FGF2—prostate cancer	0.000474	0.000964	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—JAK2—prostate cancer	0.000473	0.000962	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—VEGFA—prostate cancer	0.000472	0.00096	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—SRC—prostate cancer	0.000467	0.000951	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—SRC—prostate cancer	0.000467	0.000951	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—FGF2—prostate cancer	0.000457	0.00093	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—FGF2—prostate cancer	0.000457	0.00093	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—ERBB2—prostate cancer	0.000455	0.000926	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—VEGFA—prostate cancer	0.000455	0.000926	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—VEGFA—prostate cancer	0.000455	0.000926	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—JAK2—prostate cancer	0.000455	0.000924	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—EGFR—prostate cancer	0.000442	0.000899	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—JAK2—prostate cancer	0.000438	0.000891	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—JAK2—prostate cancer	0.000438	0.000891	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—ERBB2—prostate cancer	0.000437	0.00089	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—EGFR—prostate cancer	0.000425	0.000864	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—ERBB2—prostate cancer	0.000422	0.000858	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—ERBB2—prostate cancer	0.000422	0.000858	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—KRAS—prostate cancer	0.000418	0.00085	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—EGFR—prostate cancer	0.00041	0.000833	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—EGFR—prostate cancer	0.00041	0.000833	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—KRAS—prostate cancer	0.000401	0.000816	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—CTNNB1—prostate cancer	0.000398	0.00081	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—MMP9—prostate cancer	0.000391	0.000794	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—KRAS—prostate cancer	0.000387	0.000787	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—KRAS—prostate cancer	0.000387	0.000787	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—CTNNB1—prostate cancer	0.000383	0.000778	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—MMP9—prostate cancer	0.000375	0.000763	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—EP300—prostate cancer	0.00037	0.000753	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—CTNNB1—prostate cancer	0.000369	0.00075	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—CTNNB1—prostate cancer	0.000369	0.00075	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—MMP9—prostate cancer	0.000362	0.000736	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—MMP9—prostate cancer	0.000362	0.000736	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—SRC—prostate cancer	0.00036	0.000732	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—EP300—prostate cancer	0.000356	0.000723	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—VEGFA—prostate cancer	0.000351	0.000713	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—STAT3—prostate cancer	0.000347	0.000706	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—SRC—prostate cancer	0.000346	0.000703	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—EP300—prostate cancer	0.000343	0.000698	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—EP300—prostate cancer	0.000343	0.000698	CbGpPWpGaD
Proparacaine—SCN3A—Axon guidance—IL6—prostate cancer	0.00034	0.000691	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—VEGFA—prostate cancer	0.000337	0.000685	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—STAT3—prostate cancer	0.000334	0.000678	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—SRC—prostate cancer	0.000334	0.000678	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—SRC—prostate cancer	0.000334	0.000678	CbGpPWpGaD
Proparacaine—SCN2A—Axon guidance—IL6—prostate cancer	0.000327	0.000664	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—VEGFA—prostate cancer	0.000325	0.000661	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—VEGFA—prostate cancer	0.000325	0.000661	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—TGFB1—prostate cancer	0.000322	0.000655	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—STAT3—prostate cancer	0.000322	0.000654	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—STAT3—prostate cancer	0.000322	0.000654	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—EGFR—prostate cancer	0.000316	0.000642	CbGpPWpGaD
Proparacaine—SCN10A—Axon guidance—IL6—prostate cancer	0.000315	0.00064	CbGpPWpGaD
Proparacaine—SCN1A—Axon guidance—IL6—prostate cancer	0.000315	0.00064	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—TGFB1—prostate cancer	0.000309	0.000629	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—EGFR—prostate cancer	0.000303	0.000617	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—TGFB1—prostate cancer	0.000298	0.000606	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—TGFB1—prostate cancer	0.000298	0.000606	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—KRAS—prostate cancer	0.000298	0.000606	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—EGFR—prostate cancer	0.000292	0.000595	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—EGFR—prostate cancer	0.000292	0.000595	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—KRAS—prostate cancer	0.000286	0.000582	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—KRAS—prostate cancer	0.000276	0.000562	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—KRAS—prostate cancer	0.000276	0.000562	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—IL6—prostate cancer	0.000243	0.000493	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—IL6—prostate cancer	0.000233	0.000474	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—IL6—prostate cancer	0.000225	0.000457	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—IL6—prostate cancer	0.000225	0.000457	CbGpPWpGaD
Proparacaine—SCN3A—Developmental Biology—AKT1—prostate cancer	0.000224	0.000455	CbGpPWpGaD
Proparacaine—SCN2A—Developmental Biology—AKT1—prostate cancer	0.000215	0.000437	CbGpPWpGaD
Proparacaine—SCN10A—Developmental Biology—AKT1—prostate cancer	0.000207	0.000422	CbGpPWpGaD
Proparacaine—SCN1A—Developmental Biology—AKT1—prostate cancer	0.000207	0.000422	CbGpPWpGaD
